Janux Therapeutics, Inc.JANXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-82.23M
↓ 135% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-34.96M
Historical baseline
PeriodValueYoY Change
2025$-82.23M-87.7%
2024$-43.81M+13.4%
2023$-50.58M-17.8%
2022$-42.92M-152.8%
2021$-16.98M-288.6%
2020$-4.37M-14.1%
2019$-3.83M-